1. Suʻesuʻega ma Togafitiga mo COVID-19 (Trial version 8) e le National Health Commission o le PRC
O le aʻafiaga o le thromboembolism e maualuga i gasegase ogaoga pe ogaoga foi, ……, Anticoagulants tatau ona faaaoga prophylactically. I le tulaga o le thromboembolism, anticoagulant togafitiga e tatau ona faia e tusa ai ma faʻatonuga talafeagai.

2. — O le CELL SARS-CoV-2 Faʻamaʻi Faʻamoemoeina i Cellular Heparan Sulfate ma ACE2, Heparin ma leai-anticoagulant mafuaʻaga taofia SARSCoV-2 fusifusia ma siama.

E naʻo le pau togafitiga e faʻaaogaina ile vaega lea ole puipuiga ole maualalo ole molimoli ole heparin (LMWH), e tatau ona iloiloina i tagata mamaʻi uma ile falemaʻi e iai le niumonia fou (e aofia ai maʻi e le faitio) e aunoa ma ni faʻafitauli.
ISTH interim guidance i le amanaiaina ma le puleaina o le coagulopathy i le COVID-19

4. I tagata mamaʻi (tagata matutua ma talavou) falemaʻi ma COVID-19, faʻaaoga vailaʻau faʻataʻitaʻi faʻataʻitaʻi, pei o le maualalo o le molimoli mamafa heparin (pei o le enoxaparin), e tusa ai ma tulaga faʻalotoifale ma faʻavaomalo, e puipuia ai le vevesi thromboembolism, pe a le cont conticated.

5.All tagata gasegase ma ogaoga ma faitio COVID-19, maualalo pe feololo i le maualalo le afaina toto, ma leai contraindications e fautuaina e faaaoga vailaʻau e puipuia VTE, ma maualalo molemane mamafa heparin o le muamua filifiliga; mo le ogaoga Fatugao tuga, unparactionated heparin ua fautuaina.
Mo tagata mama ma masani, pe a fai e maualuga pe feololo le aʻafiaga o le VTE, e fautuaina le puipuia o fualaʻau pe a maeʻa ona faʻateʻaina, ma o le maualalo o le heparin o le molelaa o le filifiliga muamua.

Puipuiga ma Togafitiga o Venous Thromboembolism Faʻafesoʻotaʻi ma Coronavirus Faamaʻi 2019 siama: O se Maliega Faʻamatalaga i luma o Taiala